[Experimental study of pharmacological properties of nialamide].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D000928:Antidepressive Agents / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology; D001145:Arrhythmias, Cardiac; D001341:Autonomic Nervous System / Q000187:drug effects*; D001775:Blood Circulation / Q000187:drug effects; D001921:Brain / Q000201:enzymology; D002319:Cardiovascular System / Q000187:drug effects*; D002490:Central Nervous System / Q000187:drug effects*; D003331:Coronary Vessels / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009132:Muscles / Q000494:pharmacology; D009526:Nialamide / Q000494:pharmacology* / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D006634:Histamine H1 Antagonists; D008996:Monoamine Oxidase Inhibitors; D014665:Vasodilator Agents; D009526:Nialamide
Eksperimental'noe izuchenie farmakologicheskikh svoĭstv nialamida.